tiprankstipranks
Trending News
More News >
MUROMACHI CHEMICALS INC. (JP:4885)
:4885
Japanese Market

MUROMACHI CHEMICALS INC. (4885) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4885

MUROMACHI CHEMICALS INC.

(4885)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
¥1,478.00
▲(78.72% Upside)
Action:DowngradedDate:02/18/26
The score is primarily driven by mixed financial fundamentals: strong revenue growth and solid operating margins are offset by weakening cash flow (negative free cash flow) and still-elevated leverage. Technicals are supportive with a strong uptrend, but overbought indicators increase near-term risk. Valuation is a positive contributor with a moderate P/E and a solid dividend yield.
Positive Factors
Diversified business model
Muromachi's exposure across industrial, specialty chemicals and electronics materials provides durable demand diversification. Serving automotive, electronics and pharma reduces cyclicality and supports steadier revenue streams, enabling cross-market R&D leverage and long-term resilience.
Consistent revenue growth
Sustained ~14.8% revenue growth demonstrates expanding market share and product adoption. Over a 2-6 month horizon this growth underpins scale advantages, supports reinvestment in R&D and capacity, and provides a foundation for improving gross and operating leverage.
Healthy operating margins
Robust EBIT/EBITDA and a stable gross margin indicate effective cost management and pricing power in core products. Margin durability supports internal funding for innovation and capital needs, cushioning profits against moderate input cost swings over the medium term.
Negative Factors
Weak cash generation
Material deterioration in operating cash flow and negative free cash flow reduce financial flexibility. Over months this can constrain capex, R&D funding or dividends, and increase reliance on external financing, raising refinancing and liquidity risk for strategic initiatives.
Falling net profit margin
A declining net margin despite stable gross margins implies higher operating or non-operating costs. Persisting margin erosion can weaken return on capital and limit retained earnings, reducing capacity to invest in growth or absorb adverse industry developments.
Elevated leverage
Although leverage has improved, remaining relatively high raises interest and solvency risk. Elevated debt limits strategic flexibility, increases sensitivity to cash-flow volatility, and can constrain growth investments or force priority on deleveraging over expansion.

MUROMACHI CHEMICALS INC. (4885) vs. iShares MSCI Japan ETF (EWJ)

MUROMACHI CHEMICALS INC. Business Overview & Revenue Model

Company DescriptionMuromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals and health foods in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; and commissioned synthesis services for radioactive and stable isotope tagged compounds used in pharmaceutical and agricultural metabolic testing, as well as imports and sells active pharmaceutical ingredients. The company also provides jelly and non-alcoholic beverage products. In addition, it offers ion-exchange resins, separation membranes, and ion-exchange fibers; and solutions that meet customers' needs with water-treatment products, including filter media, equipment, and chemicals, as well as commissioned chemical processing services. Further, the company provides functional adhesives; and product contamination removal and dust removal mats, and antistatic products for use in the electronics industry, as well as engages in the commissioned manufacturing and processing of functional pastes. The company was founded in 1917 and is headquartered in Omuta, Japan.
How the Company Makes MoneyMUROMACHI CHEMICALS INC. generates revenue primarily through the sale of its chemical products across multiple sectors. The company has established key revenue streams from its industrial chemicals and specialty chemicals divisions, which serve a wide array of applications. Significant partnerships with manufacturers in the automotive and electronics industries also contribute to its earnings, as these sectors require high-quality chemical materials for production. Additionally, the company invests in R&D to develop new products and improve existing ones, thus enhancing its competitive edge and expanding its market reach.

MUROMACHI CHEMICALS INC. Financial Statement Overview

Summary
Strong and consistent revenue growth with healthy EBIT/EBITDA margins, but weakened profitability (lower net margin) and notably deteriorating cash generation (operating cash flow down and free cash flow negative). Balance sheet leverage is improving yet remains relatively high, adding risk.
Income Statement
75
Positive
Muromachi Chemicals Inc. has shown consistent revenue growth over the years, with a notable increase from 2024 to 2025. The gross profit margin remains stable, indicating efficient cost management. However, the net profit margin has decreased, suggesting rising expenses or other financial pressures. EBIT and EBITDA margins are healthy, reflecting strong operational performance.
Balance Sheet
68
Positive
The company's debt-to-equity ratio has improved over time, indicating better leverage management, but it remains relatively high compared to industry standards. Return on equity has decreased, which may concern investors. The equity ratio is stable, suggesting a balanced asset structure.
Cash Flow
60
Neutral
Operating cash flow has decreased significantly, impacting the company's ability to generate cash from operations. Free cash flow has turned negative, indicating potential liquidity issues. The free cash flow to net income ratio is concerning, suggesting challenges in converting profits into cash.
BreakdownMay 2024May 2023May 2022May 2021May 2021
Income Statement
Total Revenue6.65B6.37B6.29B5.68B4.94B
Gross Profit1.91B1.82B1.75B1.73B1.63B
EBITDA540.83M623.23M493.14M543.84M351.62M
Net Income241.28M330.20M256.30M456.27M180.71M
Balance Sheet
Total Assets5.26B5.06B4.95B4.80B4.61B
Cash, Cash Equivalents and Short-Term Investments1.06B1.05B852.61M865.36M1.00B
Total Debt1.65B1.44B1.57B1.69B2.04B
Total Liabilities2.81B2.79B3.03B3.12B3.28B
Stockholders Equity2.45B2.27B1.92B1.68B1.33B
Cash Flow
Free Cash Flow-112.86M398.53M206.91M354.57M431.82M
Operating Cash Flow215.95M637.70M317.19M524.90M487.67M
Investing Cash Flow-340.50M-232.23M-162.41M-176.28M-57.73M
Financing Cash Flow123.20M-209.95M-172.39M-483.63M-310.51M

MUROMACHI CHEMICALS INC. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price827.00
Price Trends
50DMA
1003.80
Positive
100DMA
870.29
Positive
200DMA
823.12
Positive
Market Momentum
MACD
84.91
Positive
RSI
70.73
Negative
STOCH
52.74
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4885, the sentiment is Positive. The current price of 827 is below the 20-day moving average (MA) of 1175.70, below the 50-day MA of 1003.80, and above the 200-day MA of 823.12, indicating a bullish trend. The MACD of 84.91 indicates Positive momentum. The RSI at 70.73 is Negative, neither overbought nor oversold. The STOCH value of 52.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4885.

MUROMACHI CHEMICALS INC. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥16.25B12.893.89%-3.00%-29.83%
77
Outperform
¥9.16B3.041.96%8.43%2.99%
69
Neutral
¥4.75B14.184.25%7.90%-39.51%
69
Neutral
¥10.48B20.662.98%-9.60%-38.34%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
¥12.26B93.741.06%-9.63%-1.71%
48
Neutral
¥13.27B-10.19-7.76%-19.70%-159.15%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4885
MUROMACHI CHEMICALS INC.
1,290.00
458.23
55.09%
JP:4080
Tanaka Chemical Corp.
408.00
-89.00
-17.91%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
3,930.00
1,450.87
58.52%
JP:4093
Toho Acetylene Co., Ltd.
465.00
115.85
33.18%
JP:4960
Chemipro Kasei Kaisya,Ltd.
746.00
408.48
121.02%
JP:6568
KNC Laboratories Co.,Ltd.
1,347.00
244.75
22.20%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026